Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 13208
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810S](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 1.77nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810S](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 2.69nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810S](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 5.66nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810S](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 6.61nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810S](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 15.9nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810R](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 19.6nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810S](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 23.1nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810C](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 36.3nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810C](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 48.8nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810C](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 53.2nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810S](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 57.2nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810R](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 74nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810C](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 125nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810R](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 132nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810C](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 151nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810R](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 168nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810C](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 173nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [G810R](Human)
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Sichuan Kelun-Biotech Biopharmaceutical Co.
US Patent
Affinity DataIC50: 185nMAssay Description:The three drug-resistant mutant RET enzymes were each pre-incubated with different concentrations of test compounds (in the inhibition rate test of t...More data for this Ligand-Target Pair
